What is Gale stock?
"Gale" refers to the stock ticker symbol for Galenica AG (GALE.SW), a major Swiss-based pharmaceutical and logistics company headquartered in Bern. Galenica is internationally active and operates a diverse business model that includes the distribution and management of pharmaceutical products, as well as the operation of large pharmacy chains in Switzerland such as Amavita and Sun Store. The company's stock is listed on the Swiss Stock Exchange (SWX). Galenica has a long historical background dating back to the 1927 Collaboration Pharmaceutique SA. Investors track Galenica for its stable position in the Swiss healthcare market, its logistics infrastructure through subsidiaries like Galexis AG and Alloga AG, and its historical role in pharmaceutical production and patient homecare services.
Related FAQs
Galenica Ltd maintains its corporate headquarters at Untermattweg 8, 3027 Bern, Switzerland.
Galenica operates primarily as a leading Swiss healthcare, logistics, and pharmacy network group rather than a conventional drug manufacturing pharmaceutical enterprise.
Galenica’s history spans nearly a century, dating back to 1927 when 16 pharmacists in Clarens, Switzerland, founded the Collaboration Pharmaceutique SA as a joint purchasing center.
Galenica AG, a leading fully integrated healthcare provider, pharmaceutical distributor, and pharmacy network operator in Switzerland, has its corporate headquarters located in Bern, Switzerland.
Investing in the rare earth elements sector involves identifying companies that control critical mineral reserves and advanced magnet manufacturing facilities essential for electric vehicles and defense technology.
Galenica AG is a fully public corporate entity whose shares are officially listed and traded on the SIX Swiss Exchange under the ticker symbol GALE, and it serves as a component of the prominent SMI MID index.
According to the latest financial reporting data available as of August 2026, Galenica AG recorded an annual revenue of approximately ₹502.93 billion for the year 2025. This figure represents a notable growth of 20.
GEA Group contributes significantly to global food processing and industrial manufacturing by engineering, designing, and supplying advanced processing technology, components, and comprehensive production lines.
Galenica AG operates as a leading fully integrated healthcare enterprise in Switzerland, focusing its core business activities on pharmaceutical distribution, retail pharmacy operations, and specialized health-related services.